Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.530
+0.190 (5.69%)
Jan 21, 2025, 4:00 PM EST - Market closed
Organogenesis Holdings Employees
Organogenesis Holdings had 862 employees as of December 31, 2023. The number of employees decreased by 168 or -16.31% compared to the previous year.
Employees
862
Change (1Y)
-168
Growth (1Y)
-16.31%
Revenue / Employee
$527,886
Profits / Employee
-$8,561
Market Cap
443.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ORGO News
- 2 months ago - Organogenesis Expands Manufacturing Capacity to Support Future Growth - GlobeNewsWire
- 2 months ago - Organogenesis Commends Final LCDs - GlobeNewsWire
- 2 months ago - Organogenesis Holdings, Inc. (ORGO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock - GlobeNewsWire
- 2 months ago - Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis - GlobeNewsWire
- 3 months ago - Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 4 months ago - Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers - GlobeNewsWire
- 4 months ago - Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September - GlobeNewsWire